<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Russian Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-2106</issn><issn publication-format="electronic">2412-9100</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">48518</article-id><article-id pub-id-type="doi">10.17816/0869-2106-2020-26-3-179-187</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">COVID-19: from neurotropism to neurorehabilitation under a pandemic condition</article-title><trans-title-group xml:lang="ru"><trans-title>COVID-19: от нейротропизма к нейрореабилитации в условиях пандемии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7684-9834</contrib-id><name-alternatives><name xml:lang="en"><surname>Merkulov</surname><given-names>Yury A.</given-names></name><name xml:lang="ru"><surname>Меркулов</surname><given-names>Юрий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>4181220@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0629-9659</contrib-id><name-alternatives><name xml:lang="en"><surname>Kostenko</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Костенко</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSC, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>Ekostenko58@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0368-683X</contrib-id><name-alternatives><name xml:lang="en"><surname>Merkulova</surname><given-names>Dina M.</given-names></name><name xml:lang="ru"><surname>Меркулова</surname><given-names>Дина Мироновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>dinamerk@mail.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6939-3234</contrib-id><name-alternatives><name xml:lang="en"><surname>Lyamina</surname><given-names>Nadezhda P.</given-names></name><name xml:lang="ru"><surname>Лямина</surname><given-names>Надежда Павловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, DSc, Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>lyana_n@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Moscow Centre for Research and Practice in Medical Rehabilitation, Restorative and Sports Medicine</institution></aff><aff><institution xml:lang="ru">ГАУЗ «Московский научно-практический центр медицинской реабилитации, восстановительной и спортивной медицины ДЗМ»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Scientific Research Institute of General Pathology and Pathophysiology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «НИИ общей патологии и патофизиологии»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова (Сеченовский Университет)» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2020</year></pub-date><volume>26</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>179</fpage><lpage>187</lpage><history><date date-type="received" iso-8601-date="2020-10-24"><day>24</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-10-24"><day>24</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Эко-Вектор"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2023-10-24"/></permissions><self-uri xlink:href="https://medjrf.com/0869-2106/article/view/48518">https://medjrf.com/0869-2106/article/view/48518</self-uri><abstract xml:lang="en"><p>In the review presented, based on the relevant literature data from foreign experts, the mechanisms of the neurotrophic action of the SARS-CoV-2 virus are considered, as well as the consequences of its neuroinvasion in the form of documented neurological manifestations during the COVID-19 pandemic. The risks of neurological diseases and methods of their treatment are analyzed, which in turn can affect the susceptibility to COVID-19. The range of rehabilitation syndromes is systematized, and relevant aspects of medical rehabilitation of patients after COVID-19 with an emphasis on its neurological manifestations are highlighted.</p></abstract><trans-abstract xml:lang="ru"><p>В представленном обзоре на основании актуальных литературных данных зарубежных специалистов рассмотрены механизмы нейротропного действия вируса SARS-CoV-2 и последствия его нейроинвазии в виде задокументированных неврологических проявлений в период пандемии COVID-19. Приведен анализ рисков неврологических заболеваний и методов их лечения, которые в свою очередь могут воздействовать на восприимчивость к COVID-19. Систематизирован спектр реабилитационных синдромов и освещены актуальные аспекты медицинской реабилитации пациентов, перенесших COVID-19, с акцентом на его неврологические проявления.</p></trans-abstract><kwd-group xml:lang="en"><kwd>review</kwd><kwd>coronavirus</kwd><kwd>COVID-19</kwd><kwd>neurotropism</kwd><kwd>neurological manifestations</kwd><kwd>neurorehabilitation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>обзор</kwd><kwd>коронавирус</kwd><kwd>COVID-19</kwd><kwd>нейротропизм</kwd><kwd>неврологические проявления</kwd><kwd>нейрореабилитация</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Glass W.G., Subbarao K., Murphy B., Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004;173(6):4030-9. Doi: 10.4049/jimmunol.173.6.4030.</mixed-citation><mixed-citation xml:lang="ru">Glass W.G., Subbarao K., Murphy B., Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004; 173(6):4030-9. Doi: 10.4049/jimmunol.173.6.4030.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><mixed-citation>Dubé M., Le Coupanec A., Wong A.H., Rini J.M., Desforges M., Talbot P.J. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol. 2018;92(17):e00404-18. Doi: 10.1128/JVI.00404-18.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Talbot P.J., Ekandé S., Cashman N.R., Mounir S., Stewart J.N. Neurotropism of human coronavirus 229E. Adv Exp Med Biol. 1993; 342:339-46. Doi: 10.1007/978-1-4615-2996-5_52.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Khan S., Ali A., Siddique R., Nabi G. Novel coronavirus is putting the whole world on alert. J Hosp Infect. 2020;104(3):252-3. Doi: 10.1016/j.jhin.2020.01.019.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Li Y.C., Bai W.Z., Hirano N., Hayashida T., Taniguchi T., Sugita Y. et al. Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for transsynaptic communication. J Comp Neurol. 2013;521(1):203-12. Doi: 10.1002/cne.23171.</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Li K., Wohlford-Lenane C., Perlman S., Zhao J., Jewell A.K., Re¬znikov L.R. et al. Middle East Respiratory Syndrome Coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213(5):712-22. Doi: 10.1093/infdis/jiv499.</mixed-citation><mixed-citation xml:lang="ru">Li K., Wohlford-Lenane C., Perlman S., Zhao J., Jewell A.K., Reznikov L.R. et al. Middle East Respiratory Syndrome Coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. 2016;213(5):712-22. Doi: 10.1093/infdis/jiv499.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Mao L., Wang M., Chen S., He Q., Chang J., Hong C. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol. 2020; e201127. Doi: 10.1001/jamaneurol.2020.1127.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020; 11(7):995-8. Doi: 10.1021/acschemneuro.0c00122.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>To K.F., Lo A.W. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). J Pathol. 2004;203(3):740-3. Doi: 10.1002/path.1597.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. Doi: 10.1002/path.1570.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol. 2020;1-4. Doi: 10.1002/jmv.25728.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Boonacker E., Van Noorden C.J. The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol. 2003;82(2):53-73. Doi: 10.1078/0171-9335-00302.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chan P.K., To K.F., Lo A.W., Cheung J.L., Chu I., Au F.W. et al. Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol. 2004;74(1):1-7. Doi: 10.1002/jmv.20138.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264-75. Doi: 10.1128/JVI.00737-08.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Bernstein H.G., Dobrowolny H., Keilhoff G., Steiner J. Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques. Neurochem. Int. 2018;114:55-7. Doi: 10.1016/j.neuint.2018.01.005.</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Ding Y., He L., Zhang Q., Huang Z., Che X., Hou J. et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004; 203(2):622-30. Doi: 10.1002/path.1560.</mixed-citation><mixed-citation xml:lang="ru">Ding Y., He L., Zhang Q., Huang Z., Che X., Hou J. et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2): 622-30. Doi: 10.1002/path.1560.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><mixed-citation>Gu J., Gong E., Zhang B., Zheng J., Gao Z., Zhong Y. et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005; 202(3):415-24. Doi: 10.1084/jem.20050828.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>McCray P.B. Jr., Pewe L., Wohlford-Lenane C., Hickey M., Man¬zel L., Shi L. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007; 81(2):813-21. Doi: 10.1128/JVI.02012-06.</mixed-citation></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. Doi: 10.1001/jama.2020.1585.</mixed-citation><mixed-citation xml:lang="ru">Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. Doi: 10.1001/jama.2020.1585.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Hadziefendic S., Haxhiu M.A. CNS innervation of vagal preganglionic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus. J Auton Nerv Syst. 1999;76(2-3): 135-45. Doi: 10.1016/s0165-1838(99)00020-x.</mixed-citation><mixed-citation xml:lang="ru">Hadziefendic S., Haxhiu M.A. CNS innervation of vagal pregan¬gli¬onic neurons controlling peripheral airways: a transneuronal labeling study using pseudorabies virus. J Auton Nerv Syst. 1999;76(2-3): 135-45. Doi: 10.1016/s0165-1838(99)00020-x.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Brugliera L., Spina A., Castellazzi P., Cimino P., Tettamanti A., Houdayer E. et al. RehabilitationofCOVID-19 patients. J Rehabil Med. 2020;25(7):439-41. Doi: 10.1016/j.arcped.2018.08.001.</mixed-citation><mixed-citation xml:lang="ru">Brugliera L., Spina A., Castellazzi P., Cimino P., Tettamanti A., Houdayer E. et al. Rehabilitation of COVID-19 patients. J Rehabil Med. 2020;25(7):439-41. Doi: 10.1016/j.arcped.2018.08.001.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">McNeary L., Maltser S., Verduzco-Gutierrez M. Navigating Coro¬na¬virus Disease 2019 (Covid-19) in physiatry: a CAN report for inpatient rehabilitation facilities. PMR. 2020;12(5):512-5. Doi: 10.1002/pmrj.12369.</mixed-citation><mixed-citation xml:lang="ru">McNeary L., Maltser S., Verduzco-Gutierrez M. Navigating Coronavirus Disease 2019 (Covid-19) in physiatry: a CAN report for inpatient rehabilitation facilities. PMR. 2020;12(5):512-5. Doi: 10.1002/pmrj.12369.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><mixed-citation>Asadi-Pooya A.A., Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832. Doi: 10.1016/j.jns.2020.116832.</mixed-citation></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8. Doi: 10.1016/j.ijid.2020.03.062.</mixed-citation><mixed-citation xml:lang="ru">Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takami¬no J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-8. Doi: 10.1016/j.ijid.2020.03.062.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Grif¬fith B. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;201187. Doi: 10.1148/radiol.2020201187.</mixed-citation><mixed-citation xml:lang="ru">Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;201187. Doi: 10.1148/radiol.2020201187.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Gutiérrez-Ortiz C., Méndez A., Rodrigo-Rey S. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;10.1212/WNL.0000000000009619. Doi: 10.1212/WNL.0000000000009619.</mixed-citation><mixed-citation xml:lang="ru">Gutiérrez-Ortiz C., Méndez A., Rodrigo-Rey S. Miller Fisher Syn¬drome and polyneuritis cranialis in COVID-19. Neurolo¬gy. 2020; 10.1212/WNL.0000000000009619. Doi: 10.1212/WNL.0000000000009619.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Zhao H., Shen D., Zhou H., Liu J., Chen S. Guillain–Barré syn¬dro¬me associated with SARS-CoV-2 infection: causality or coinci¬den¬ce? Lancet Neurol. 2020;19(5):383-4. Doi: 10.1016/S1474-4422(20)30109-5.</mixed-citation><mixed-citation xml:lang="ru">Zhao H., Shen D., Zhou H., Liu J., Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-4. Doi: 10.1016/S1474-4422(20)30109-5.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. Doi: 10.1016/S0140-6736(20)30211-7.</mixed-citation><mixed-citation xml:lang="ru">Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. et al. Epide¬mio-logical and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-13. Doi: 10.1016/S0140-6736(20)30211-7.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><mixed-citation>Talan J. Neurologists in Italy to colleagues in US: Look for poorly-defined neurologic conditions in patients with COVID-19. Neurology Today. 2020;20(8):11. Doi: 10.1097/01.nt.0000662096.35724.1f.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Xiang Y.T., Zhao Y.J., Liu Z.H., Li X.H., Zhao N., Cheung T. et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Bio Sci. 2020;16:1741-4. Doi: 10.7150/ijbs.45072.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Association of British Neurologists Guidance on COVID-19 for people with neurological conditions, their doctors and carers. Version 4, 25 March 2020. Available at: https://www.neural.org.uk/resource_library/association-of-british-neurologists-guidance-on-covid-19/ (accessed 12 April 2020).</mixed-citation></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Martynov M.Yu., Shamalov N.A., Khasanova D.R., Voznyuk I.A., Alasheev A.M., Kharitonova T.V. Management of patients with acute cerebrovascular accident in the context of the COVID-19 pandemic. Temporary guidelines. Version 1. 06.04.2020. Available at: http://www.evidence-neurology.ru/evidentiary-medicine/klinicheskie-rekomendatsii/vedenie-patsientov-s-ostrimi-na/ (accessed 12 April 2020). (In Russian)</mixed-citation><mixed-citation xml:lang="ru">Мартынов М.Ю., Шамалов Н.А., Хасанова Д.Р., Вознюк И.А., Алашеев А.М., Харитонова Т.В. Ведение пациентов с острыми нарушениями мозгового кровообращения в контексте пандемии COVID-19. Временные методические рекомендации. Версия 1. 06.04.2020. Available at: http://www.evidence-neurology.ru/evidentiary-medicine/klinicheskie-rekomendatsii/vedenie-patsientov-s-ostrimi-na/ (дата обращения 12.04.2020).</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><mixed-citation>Jin H., Hong C., Chen S., Zhou Y., Wang Y., Mao L. et al. Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists. Stroke Vasc Neurol. 2020; svn-2020-000382. Doi: 10.1136/svn-2020-000382.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Leocani L., Diserens K. Neurorehabilitation facing the COVID-19 pandemic. EAN pages. Published online April 15, 2020. Available at: https://www.eanpages.org/2020/04/15/neurorehabilitation-facing-the-covid-19-pandemic/ (accessed 20 April 2020).</mixed-citation></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">EAN Scientific Panel Coma and Chronic Disorders of Con¬sci¬ous¬ness. Neurorehabilitation of patients with severe brain injury during the Covid-19 epidemic. EAN pages. Published online April 9, 2020. Available at: https://www.eanpages.org/2020/04/09/neuro¬rehabilitation-of-patients-with-severe-brain-injury-during-the-covid-19-epidemic/ (accessed 12 April 2020).</mixed-citation><mixed-citation xml:lang="ru">EAN Scientific Panel Coma and Chronic Disorders of Consciousness. Neurorehabilitation of patients with severe brain injury during the Covid-19 epidemic. EAN pages. Published online April 9, 2020. Available at: https://www.eanpages.org/2020/04/09/neurorehabilitation-of-patients-with-severe-brain-injury-during-the-covid-19-epidemic/ (accessed 12 April 2020).</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><mixed-citation>Boldrini P., Bernetti A., Fiore P. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine (PRM) physicians’ activities in Italy. An official document of the Italian PRM Society (SIMFER). Eur J Phys Rehabil Med. 2020 Mar 16. Doi: 10.23736/S1973-9087.20.06256-5.</mixed-citation></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Coraci D., Fusco A., Frizziero A., Giovannini S., Biscotti L., Padua L. Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19. J Med Virol. 2020 Apr 3. Doi: 10.1002/jmv.25829.</mixed-citation><mixed-citation xml:lang="ru">Coraci D., Fusco A., Frizziero A., Giovannini S., Biscotti L., Pa¬dua L. Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19. J Med Virol. 2020 Apr 3. Doi: 10.1002/jmv.25829.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Levy J., Léotard A., Lawrence C., Paquereau J., Bensmail D., An¬nane D. et al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments with severe COVID-19. Ann Phys Rehabil Med. 2020;S1877-0657(20)30077-4. Doi: 10.1016/j.rehab.2020.04.002.</mixed-citation><mixed-citation xml:lang="ru">Levy J., Léotard A., Lawrence C., Paquereau J., Bensmail D., Anna¬ne D. et al. A model for a ventilator-weaning and early rehabilitation unit to deal with post-ICU impairments with severe COVID-19. Ann Phys Rehabil Med. 2020; S1877-0657(20)30077-4. Doi: 10.1016/j.rehab.2020.04.002.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Carda S., Invernizzi M., Bavikatte G., Bensmaïl D., Bianchi F., Deltombe T. et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: the clinician’s view. Ann Phys Rehabil Med. 2020;S1877-0657(20)30076-2. Doi: 10.1016/j.rehab.2020.04.00.</mixed-citation><mixed-citation xml:lang="ru">Carda S., Invernizzi M., Bavikatte G., Bensmaïl D., Bianchi F., Deltombe T. et al. The role of physical and rehabilitation medicine in the COVID-19 pandemic: the clinician’s view. Ann Phys Rehabil Med. 2020; S1877-0657(20)30076-2. Doi: 10.1016/j.rehab.2020.04.00.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
